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47,XXY (KS) occurs in 1:650 male births, though less than 25% are ever identified. We
assessed stability of neurocognitive features across diverse populations and quantified
factors mediating outcome. Forty-four boys from the Netherlands (NL) and 54 boys
from the United States (US) participated. The Wechsler Intelligence Scales assessed
intellectual functioning; the ANT program evaluated cognitive function; and the CBCL
assessed behavioral functioning. ANOVA was used for group comparisons. Hierarchi-
cal regressions assessed variance explained by each independent variable: parental
education, timing of diagnosis, testosterone, age, and nationality. Parental education,
timing of diagnosis, and hormonal treatment all played an important role in
neurocognitive performance. The observed higher IQ and better attention regulation
in the US group as compared to the NL group was observed with decreased levels of
behavioral problems in the US group. Cognitive measures that were different between
the NL and US groups, i.e., attention regulation and IQ scores, were also significantly
influenced by external factors including timing of diagnosis, testosterone treatment,
and parental education. On the ANT, a cognitive phenotype of 47,XXY was observed,
with similar scoreson9out of the10ANTsubtests for theNLandUSgroups. This study
lays additional features to the foundation for an algorithm linking external variables to
outcome on various neurodevelopmental measures.
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1 | INTRODUCTION
47,XXY (Klinefelter Syndrome) is the most common X and Y
chromosomal variation occurring in between 1:500 and 1:1000 live
male births (Nielsen & Wohlert, 1991; Perwein, 1984). However, only
10% of 47,XXY cases are diagnosed prenatally, and less than 25% of
cases are ever diagnosed (Abramsky & Chapple, 1997; Bojesen, Juul &
Gravholt, 2003). The neurodevelopmental profile of boys with 47,XXY
is variable but includes language-based learning difficulties, develop-
mental dyspraxia, executive dysfunction, and an increased risk of social
cognitive impairments (Boada, Janusz, Hutaff-Lee, & Tartaglia, 2009;
Leggett, Jacobs, Nation, Scerif, & Bishop, 2010; Ross et al., 2012;
Samango-Sprouse & Rogol, 2002; Simpson et al., 2003).
While consistent deficiencies are observed across multiple
studies, there is variability in both function and presentation. For
instance, estimates of ADHD in boys with 47,XXY range from 34% to
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63% (Lee et al., 2011; Tartaglia, Ayari, Hutaff-Lee, & Boada, 2012).
Wide divergence is also observed in the intelligence profile of boys
with 47,XXY, with the majority of boys exhibiting intact cognitive
profiles and IQswithin the normal range (and some in the gifted range),
and fewwithmild intellectual disabilities (Leggett et al., 2010; Simpson
et al., 2003). A host of genetic and environmental factors are influential
in this phenotypic variability, although the relative contributions of
these multiple factors remains unclear. Genetic influences include
skewed X inactivation (Iitsuka et al., 2001), parental origin of the
additive X chromosome (Bruining et al., 2010), mosaicism (Mohd &
Jalaludin, 2016), and a positive family history of learning disabilities
(Samango-Sprouse, Stapleton, Sadeghin, & Gropman, 2013, Samango-
Sprouse et al., 2014). External factors include prenatal versus postnatal
diagnosis (Girardin et al., 2009; Ross et al., 2012; Simpson et al., 2003),
ancillary services received, and androgen replacement therapy
implemented during infancy and/or at the onset of puberty (Mehta
& Paduch, 2012; Patwardhan, Eliez, Bender, Linden, & Reiss, 2000;
Ross et al., 2005; Samango-Sprouse, Sadeghin, et al., 2013; Samango-
Sprouse et al., 2015).
Boys who are prenatally diagnosed are more likely to receive
earlier ancillary services and/or hormonal treatment when there is a
greater degree of neural plasticity, and positive response to treatment
(Ross et al., 2017). Linden and Bender (2002), for instance,
demonstrated a decrease in neurodevelopmental problems, particu-
larly learning disabilities, in prenatally diagnosed as compared to
postnatally diagnosed children with X and Y Chromosomal disorders.
In this study, we investigated two populations of boys with 47,
XXY: one in theUnited States (US) and one in theNetherlands (NL).We
examined the neurocognitive and behavioral profiles of these 47,XXY
populations and assessed variability within them.We investigated how
stable or “penetrant” the phenotype of 47,XXY is, and aimed to identify
external factors that contribute to the observed phenotypic variability.
These findings have theoretical relevance, in terms of both vulnerabil-
ity mechanisms as well as clinical treatment in 47,XXY. A predictive
algorithm detailing the most prominent contributors and their
respective effect size on presentation could be very valuable in
providing more personalized and targeted treatment options given the
wide range of developmental function in 47,XXY.
2 | MATERIALS AND METHODS
2.1 | Participants
In the NL, 44 boys with 47,XXY participated as part of a large study on
cognition and behavioral constructs in this disorder. The participants
ranged from 8 to 18 years (mean 11.8 ± 3.5). The subjects included
children with a prenatal diagnosis, children recruited through support
groups, and those referred due to known developmental deficits. In the
US, 54 boys with 47,XXY participated with ages ranging from 8 to
18 years (mean 11.5 ± 2.6). The group of US boys with 47,XXY were
recruited through a diagnostic center as part of their routine
neurodevelopmental care.
NL and US ages were not significantly different (p =.61). The
presence of an extra X chromosome (non-mosaic) was confirmed using
standard chromosomal testing. Informed consent was obtained from
each study participant according to the Declaration of Helsinki. The
Dutch Central Committee on Research Involving Human Subjects and
the Western Institutional Review Board (WIRB) approved the study
protocol (#20081226).
2.2 | Intellectual functioning
IQ profiles were measured using the English and Dutch versions of the
Wechsler Intelligence Scales for Children (WISC) (Wechsler, 1991),
and the Wechsler Intelligence Scales for Adults (WAIS) for study
participants over 16 years of age (Wechsler, 2005). As in the original
versions, the Dutch versions have adequate reliability and validity. The
WISC generates a verbal IQ (VIQ), and a performance IQ (PIQ)
(M = 100, SD = 15) through 12 subtests. VIQ assesses verbal skills such
as verbal reasoning and verbal comprehension. PIQ assesses various
visual-spatial abilities and perceptional reasoning.
2.3 | Parental education
Parental education was assessed according to the criteria of Hollings-
head, employing a scale from 0 (no formal education) to 7 (graduate/
professional training) (Hollingshead, 1975). Other scores of this scale
include: 1 (less than seventh grade), 2 (junior high school), 3 (partial
high school), 4 (high school graduate), 5 (partial college or specialized
training), and 6 (standard college/university graduation) (Hollingshead,
1975). Level of education was averaged over both parents.
2.4 | Cognitive test battery
2.4.1 | Amsterdam Neuropsychological Tasks
The Amsterdam Neuropsychological Tasks (ANT) program (de
Sonneville, 1999) has proven to be helpful in defining neurocognitive
profiles in diverse populations (Rommelse et al., 2008; Serra et al.,
2003) and several studies have demonstrated satisfactory psycho-
metric properties of the ANT (for a review see de Sonneville, 2005).
Stimuli are presented on the computer screen and participants
respond using a mouse. Each subtest is preceded by illustration trials
and practice trials. The ANT generates norm scores based on
nonlinear regression functions capturing the normative data in the
age range of 4–66 years with total sample sizes varying between
2,500 and 6,000 subjects, depending on type of task. Higher
(positive) Z scores represent more impaired performance. A pilot
study was performed in the US and showed that 15 typically
developing children (aged between 8 and 18 years) had Z scores
between Z − 0.5 and Z + 0.5 (i.e., well within the Dutch normal range).
Based on this pilot study we were confident in using the Dutch norm
scores for the US sample. Supplementary Table S1 provides an
explanation of all subtests on the ANT.
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2.4.2 | Emotional/behavioral problems
The norm-referenced Child Behavior Checklist (CBCL) describes
recent emotional and behavioral functioning in children 6–18 years
of age (Achenbach & Edlebrock, 1991). This assessment requires
caregivers to fill out a checklist of behavioral or emotional problems
exhibited by the child in the last twomonths. The items on the checklist
are measured on a three point Likert scale. The CBCL has two
empirically derived broadband scales (Externalizing and Internalizing)
and eight syndrome scales (Anxious/Depressed, Withdrawn/De-
pressed, Somatic Complaints, Rule Breaking Behavior, Aggressive
Behavior, Social Problems, Thought Problems, and Attention Prob-
lems). The Externalizing scale is comprised of items from the Rule
Breaking and Aggressive Behavior syndrome scales; the Internalizing
scale is comprised of items from the Anxious/Depressed, Withdrawn/
Depressed, and Somatic Complaints syndrome scales. Raw scores for
each scale are converted to norm-referenced T-scores (M = 50,
SD = 10). The clinically relevant cutoff points of the CBCL broadband
scores are T < 60 reflecting the normal range of functioning,
60 < T < 65 reflecting the borderline range, and T > 65 reflecting the
clinical range.
2.5 | Statistical analyses
Group comparisons of IQ and age (US/NL) were analyzed using
Analysis of Variance (ANOVA), as these variables were normally
distributed. Group comparisons of CBCL scores, parental education,
number of children with prenatal/postnatal diagnosis, number of
testosterone treated/non-treated children, number of children start-
ing testosterone treatment in infancy versus childhood/adolescence,
and the ANT parameters were analyzed using non-parametric (Mann–
Whitney) tests, since these variables were not normally distributed.
External factors, i.e., parental education, prenatal/postnatal diagnosis,
and testosterone treatment (yes/no), were used to predict cognitive
and behavioral scores using regression analyses, which do not require a
normal distribution, in the US group and NL group, collapsed. Age was
added to control for developmental effects. A hierarchical regression
was used with age, parental education, pre/postnatal diagnosis, and
testosterone treatment (yes/no) as predictors in the first box (stepwise
selection). Country was added in the second box (remove selection) to
test if, after explaining variance using parameters of interest in the first
box, “country” was still a significant factor in explaining remaining
variance (i.e., if it was required to improve the regression model).
Because the number of children starting testosterone treatment in
infancy versus childhood/adolescence was only applicable for the US
sample, separate regression analyses were performed for this specific
subgroup to predict cognitive and behavioral scores, with early versus
late testosterone treatment and age as predictors (stepwise selection).
Multicollinearity among predictors was also checked for in the
regression analyses. For the group-wise (US/NL) nonparametric
comparisons across multiple cognitive domains (ANT) and multiple
behavioral domains (CBCL), the threshold for significance was set at
p = .01 to correct for multiple comparisons. For other group
comparisons that did not involve multiple comparisons, and for
regression analyses, the threshold for significance was set at p = .05.
3 | RESULTS
3.1 | Group differences in environmental factors
3.1.1 | Parental education
Distribution of parental education scores in the US and NL samples are
presented in Figure 1. Incomplete parental education data from 10 NL
participants were removed. Average parental education was 5.7 (± 1.1)
in the US and 4.6 (± 1.4) in the NL, which were significantly different
(z = −3.8, p < .001). The higher score on parental education indicates
more years of education. Average parental educationwas not different
for testosterone treatment versus nontreated group, or for the
prenatally diagnosed versus postnatally diagnosed group.
3.1.2 | Testosterone treatment
Distribution of testosterone treated versus nontreated in the US and
NL samples are presented in Table 1. Of the NL children, 16.7% had
received or were receiving testosterone treatment (vs. 83.3% non-
treated children). Of the US children, 55.6% had received or were
receiving testosterone treatment (vs. 44.4% non-treated). The group
difference in ratio of testosterone treated and non-treated children
was significant (z = −3.8, p < .001).
FIGURE 1 Average parental education level among the United
States and Netherlands cohorts, as characterized by Hollingshead
criteria
TABLE 1 This table presents the distribution of children who
received testosterone treatment versus nontreated in the US and NL
samples
US NL
Testosterone treatment 30 7
Nontreated 24 37
Prenatal diagnosis 49 24
Postnatal diagnosis 5 20
This table also presents the total number of participants diagnosed either
prenatally or postnatally in the US and NL samples.
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3.1.3 | Prenatal/postnatal diagnosis
Distribution of timing of diagnosis (prenatally vs. postnatally) in the US
and NL samples are also presented in Table 1. Of the NL children,
54.5%were prenatally diagnosed (vs. 45.5%postnatally diagnosed). Of
theUS children, 90.7%were prenatally diagnosed (vs. 9.3% postnatally
diagnosed). The group difference in ratio of pre/postnatally diagnosed
children was significant (z = −4.1, p < .001).
3.2 | Group differences in intellectual and cognitive
functioning
Incomplete data from two participants in the NL sample were
removed. In the NL sample, average VIQ was 78.1 (± 13.7) and
average PIQ was 85.1 (± 15.7). In the US sample, average VIQ was
109.3 (± 11.3) and average PIQ was 114.9 (± 12.1). Group differences
in VIQ and PIQ were significant: F (1,94) = 148.8, p < 0.001 and F
(1,94) = 110.6, p < 0.001, respectively.
A summary of group differences in cognitive functioning as
measured by the ANT is presented in Table 2. First, when comparing
the average Z scores across the US sample andNL sample, themajority
of cognitive parameters did not show significant group differences.
However, as compared to the US sample, the NL sample showed more
severe impairments in attention regulation as expressed in stability of
tempo (z = −3.3, p < 0.001).
Next, in order to assess developmental risk within both samples,
we calculated the percentage of children in the “intact/borderline”
range (Z < 2.0, i.e., below 98th percentile) and “significantly impaired”
range (Z > 2.0, i.e., above 98th percentile) for each cognitive domain.
Performance was categorized on an individual level for each cognitive
domain (Table 3).
We also calculated the percentage of children (who completed at
least 8 out of 10 tests on the ANT) showing various levels of severity in
their cognitive phenotype, as expressed by the number of cognitive
domains that were affected (Figure 2). In the US group, a majority of
TABLE 2 Z scores on neuropsychological tests (ANT program) within the US and NL samples
Task US NL Group differences
Attention regulation: Stability of tempo 1.16 ± .18 2.57 ± .32 p = .001*
Attentional control: Misses 1.74 ± .36 0.70 ± .26 p = .03
Inhibition 1.21 ± .27 1.28 ± .39 p = .45
Mental flexibility 1.64 ± .23 1.74 ± .39 p = .54
Motor fluency 1.22 ± .19 1.16 ± .16 p = .59
Motor flexibility 3.22 ± .49 2.10 ± .29 p = .16
Face processing 1.50 ± .41 1.18 ± .26 p = .54
Facial emotion recognition: Happy 0.81 ± .25 1.84 ± .20 p = .03
Facial emotion recognition: Sad 0.24 ± .23 0.90 ± .26 p = .31
Facial emotion recognition: Angry 0.92 ± .23 0.94 ± .24 p = .73
ANT, Amsterdam Neuropsychological Tasks battery.
Higher scores indicate more impaired performance.
*Significant at (p = .01) threshold, corrected for multiple comparisons.
TABLE 3 Percentages of children with intact and impaired scores on neuropsychological tests (ANT program) within the US and NL samples
US sample NL sample
Subtest Normal/borderline (%)a Impaired (%)b Normal/borderline (%)a Impaired (%)b Group differences
Attention regulation (stability of tempo) 77.1 22.9 42.9 57.1 p = .001*
Attentional control: Misses 70.8 29.2 81.0 19.0 p = .27
Inhibition 74.1 25.9 72.1 27.9 p = .83
Mental flexibility 64.8 35.2 64.3 35.7 p = .96
Motor fluency 79.2 20.8 79.6 21.4 p = .94
Motor flexibility 44.4 55.6 55.8 44.2 p = .29
Face processing 77.4 22.6 75.0 25.0 p = .79
Facial emotion recognition: Happy 75.0 25.0 56.4 43.6 p = .08
Facial emotion recognition: Sad 83.7 16.3 77.8 23.1 p = .44
Facial emotion recognition: Angry 75.8 24.2 74.4 25.6 p = .89
aZ < 2.0.
bZ > 2.0.
*Significant at (p = .01) threshold, corrected for multiple comparisons.
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the children (77.8%) had 0–3 cognitive domains affected, which
suggests less effect of the additive X. There was only one US
participant (2.2%) in the 7–10 cognitive domains affected range. In the
NL group, the children were more evenly distributed across the range
of cognitive domains affected. Of theNL children, 59.5% fell within the
0–3 cognitive domains affected, while 16.2% fell in the 7–10 cognitive
domains affected range.
However, χ2 analysis showed no significant differences in
distribution between the US and NL groups (z = −1.51, p = .13). Also,
the average percentage of affected domains (31.9% (± 23.9) for the NL
sample and 28.4% (± 20.3) for the US sample) was not different across
groups, (z = −0.40, p = .68).
3.3 | Group differences in emotional/behavioral
problems
Incomplete CBCL data from eight participants in the NL sample were
removed. Average CBCL T-scores for Total Problems were signifi-
cantly higher in the NL sample (63.9 ± 9.6) than the US sample
(54.8 ± 11.6), z = −3.5, p < 0.001. Similarly, scores for Internalizing
Problems were significantly higher in the NL sample (63.4 ± 10.6) than
the US sample (56.5 ± 11.7), z = −2.74, p = .006. Average T-scores for
Externalizing Problems were 58.1 (±12.2) in the NL sample and 59.3
(± 11.7) in the US sample, which were not significantly different
(z = −2.4, p = .015). See Table 4.
3.4 | Factors predicting intellectual, cognitive, and
behavioral functioning
3.4.1 | Intellectual and cognitive functioning
For VIQ a significant model was found, F (3,83) = 20.9, p < .001,
explaining 43.1% of the total variance in VIQ. This model included
three significant predictors: parental education (t = 3.9, p < .001,
β = .34), pre/postnatal diagnosis (t = −4.6, p < .001, β = −.39), and
testosterone treatment (t = 3.8, p < .001, β = .33). Taken together,
higher parental education, prenatal diagnosis, and testosterone
treatment were significant predictors of higher VIQ.
A significant model was also found for PIQ, F (3,83) = 22.6,
p < .001, explaining 45.0% of the total variance in PIQ. This model
included three significant predictors: parental education (t = 3.8,
p < .001, β = .32), pre/postnatal diagnosis (t = −4.8, p < .001,
β = −.40), and testosterone treatment (t = 4.4, p < .001, β = .36). Higher
parental education, prenatal diagnosis, and testosterone treatment
were thus significant predictors of higher PIQ.
For Attention Regulation (stability of reaction times in the
attention task) a significant model was found, F (2,77) = 6.6, p = .002,
explaining 14.7% of the total variance in Attention Regulation. This
model included two significant predictors: pre/postnatal diagnosis
(t = −2.4, p = .017, β = −.26) and testosterone treatment (t = −2.8,
p = .006, β = −.30). Prenatal diagnosis and testosterone treatmentwere
thus significant predictors of better Attention Regulation.
Finally, for Motor Fluency, a significant model was found,
F (1,83) = 4.9, p = .029, explaining 5.6% of the total variance in Motor
Fluency. This model included one significant predictor: pre/postnatal
diagnosis (t = 2.2, p = .029, β = .24). Prenatal diagnosis was thus a
significant predictor of better Motor Fluency.
For each of the preceding independent variables (VIQ, PIQ,
Attention Regulation, and Motor Fluency), the predictor “country,”
which was added in block two of the hierarchical regression, did not
significantly improve the model.
No significant regression models were found for Face Processing,
Emotion Recognition, Attentional Control, Mental Flexibility. For an
FIGURE 2 Number of cognitive domains affected among subjects
in the United States and Netherlands cohorts, as measured by the
Amsterdam Neuropsychological Tasks
TABLE 4 Percentages of children with CBCL Problem Scales scores in the normal, borderline and clinical range within the US and NL Samples
US NL
Problem Scale Normal (%)a Borderline (%)b Clinical (%)c Normal (%)a Borderline (%)b Clinical (%)c Group differences
Total 70.4 7.4 22.2 36.1 16.7 47.2 p = .002*
Internalizing 63.0 7.4 29.6 38.9 8.3 52.8 p = .02
Externalizing 74.1 9.3 16.7 55.6 11.1 33.3 p = .06
CBCL, childhood behavioral checklist for ages 6–18
*Significant at (p = .01) threshold, corrected for multiple comparisons
aT < 60.
b60 < T < 64.
cT > 65.
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overview of all significant predictors of intellectual and cognitive
functioning, see Table 5.
Multicollinearity among predictors in the regression analyses
revealed all variance inflation factor (VIF) values were approximately 1,
demonstrating that these predictors (parental education levels,
testosterone treatment, and time of diagnoses) are not intercorrelated.
Thus, parental education was not associated with testosterone
treatment or time of diagnoses.
3.4.2 | Behavioral functioning
For total level of emotional/behavioral problems (CBCL Total score) a
significant model was found, F (2,84) = 7.8, p = .001, explaining 15.7%
of observed variance. This model included two significant predictors:
testosterone treatment (t = −3.0, p = .003, β = −.30) and pre/postnatal
diagnosis (t = 2.7, p = .008, β = .27). The predictor “country,”which was
added in block two of the hierarchical regression, did not significantly
improve the model. A prenatal diagnosis and testosterone treatment
were significant predictors of fewer emotional/behavioral problems.
When looking at the two CBCL dimensions (Internalizing/
Externalizing), a significant model was found for Internalizing Problems
F (1,85) = 10.0, p = .002, explaining 10.5% of observed variance. For
Internalizing Problems, one significant predictor was found: pre/
postnatal diagnosis (t = 3.0, p = .002, β = .32). Also for CBCL External-
izing problems, a significant model was found, explaining 6.0% of the
variance (F (1,85) = 5.4, p = .022). This model included one significant
predictor: testosterone treatment (t = −2.3, p = .022, β = −.25). The
predictor “country,” which was added in block two of the hierarchical
regressions, did not significantly improve the models. Prenatal
diagnosis was thus a significant predictor of lower levels of
internalizing problems, and testosterone treatment was a significant
predictor of externalizing problems (Table 5).
With regard to the subgroups of testosterone-treated subjects
(n = 42), some subjects began treatment in infancy (n = 16), while some
subjects began treatment in childhood or adolescence (≥ age 6 years,
n = 23). Therefore, within the testosterone treated sample, it was
evaluatedwhether the variable “timing of treatment” (with the variable
“age” added to control for maturational effects) predicted any of the
cognitive and behavioral measures. The only cognitive/behavioral
dimension that was significantly predicted by timing of treatment was
Inhibition, which showed a significant model (F (1,47) = 5.0, p = .03)
explaining 9.6% of the variance. This included one predictor which was
timing of treatment (t = 2.2, p = .03, β = .31). Thus, testosterone
treatment beginning in infancy, rather than childhood/adolescence,
was associated with better inhibitory control. No significant models
were found for the other cognitive/behavioral measures.
4 | DISCUSSION
To our knowledge, this is the first international and collaborative
investigation using IQ assessment, a computerized neuropsychological
TABLE 5 Predictors of intellectual, cognitive, and behavioral outcome in the US and NL samples, collapsed
Test Dependent variable Total variance explained (R2) Significant independent variables (variance explained) p-value
WISC VIQ 43.1% Parental Ed. (20.1%) p < .001
WISC VIQ 43.1% Pre/post Dx (12.6%) p < .001
WISC VIQ 43.1% Testosterone (10.5%) p < .001
WISC PIQ 53.5% Parental Ed. (19.0%) p < .001
WISC PIQ 53.5% Pre/post Dx (13.0%) p < .001
WISC PIQ 53.5% Testosterone (13.0%) p < .001
ANT Attention regulation 14.7% Testosterone (8.1%) p = .006
ANT Attention regulation 14.7% Pre/post Dx (6.6%) p = .017
ANT Face processing n.s
ANT Emotion recog. (Sad) n.s.
ANT Emotion rec (Happy) n.s.
ANT Attentional control (Misses) n.s.
ANT Inhibition 9.6% Timing of test. Treatment (9.6%) p = .03
ANT Mental flexibility n.s.
ANT Motor fluency 5.6% Pre/post Dx (5.6%) p = .029
ANT Motor flexibility n.s.
CBCL Total 15.7% Testosterone (8.3%) p = .003
CBCL Total 15.7% Pre/post Dx (7.4%) p = .008
CBCL Internalizing 10.5% Pre/post Dx (10.5%) p = .002
CBCL Externalizing 6.0% Testosterone (6.0%) p = .022
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assessment, and parental questionnaires to further define the neuro-
cognitive phenotype of boys with 47,XXY. Our findings suggest that
verbal intelligence (VIQ), performance intelligence (PIQ), attention
regulation, and degree of behavioral problems show significant
differences across two samples, with a variety of critical factors
contributing substantially to this divergence. These factors included
parental education, time of diagnosis (prenatal/postnatal), as well as
testosterone treatment. Our study provides insight into external
factors that contribute to this variability in neuropsychological
assessments, IQ measures, and problematic behavior observed in
boyswith 47,XXY. It also highlights some penetrant aspects of 47,XXY,
as seen by the similar group scores on 9 out of the 10 ANT subtests.
These findings are more robust given that the participants span two
countries with diverse populations in terms of parental education,
timing of diagnosis, treatment procedures, and interventional strate-
gies. This study also provides an estimate of effect sizes on intellectual,
cognitive, and behavioral outcome that has not been previously
described.
Our findings are consistent with previous findings that have
revealed boys with 47,XXY may exhibit deficits in executive
functioning (Kompus et al., 2011; van Rijn & Swaab, 2015). Executive
functioning is governed by the frontal lobe, and boyswith 47,XXY have
abnormal structure and function of this area of the brain (van Rijn &
Swaab, 2015). Based on the findings in this study, it may be
hypothesized that timing of diagnosis and testosterone treatment
could influence brain function and neurodevelopment in a positive
manner. Further, our results reveal that testosterone treatment
beginning in infancy, rather than childhood/adolescence, was associ-
ated with better inhibitory control. These results further support
previous studies suggesting that testosterone treatment may have a
positive impact on neurodevelopment outcome in boys with 47,XXY
(Mandoki & Sumner, 1991; Patwardhan et al., 2000; Ross et al., 2005;
Ross et al., 2017; Samango-Sprouse, Sadeghin, et al., 2013).
Our findings suggest a neural plasticity to intellectual potential in
boyswith 47,XXY by three salient factors which are prenatal diagnosis,
testosterone treatment, and parental education. Equally important,
our findings support the need for systematic screening that could lead
to prenatal diagnosis, improved parent support, and targeted early
intervention. Based on our results, these proactive factors may
minimize the negative impact of a prolonged diagnostic odyssey,
optimize intellectual potential, and reduce behavioral disturbances.
Timing of diagnosis (prenatal versus postnatal) predicted the
widest range of dependent variables—six in total (VIQ, PIQ, Attention
Regulation, Motor Fluency, CBCL Total, CBCL Internalizing). This
further solidifies the importance of timing of diagnosis and its
significant impact on the neurodevelopmental outcome for boys
with 47,XXY. Based on the results of this study and others, it is evident
that comprehensive screening for the early diagnosis of 47,XXY would
have a myriad of potential benefits for these children. Prenatal
diagnosis allows for a proactive approach to care that includes early,
dynamic treatment and the construction of a developmental
infrastructure that addresses potential problems before their onset.
Conversely, a reactive and variable care plan is more common in
postnatally diagnosed children, who often do not receive appropriate
services before the onset of problems.
Recently, several published articles have demonstrated the
positive effect of testosterone on behavioral function and neuro-
developmental outcome (Mehta & Paduch, 2012; Patwardhan et al.,
2000; Samango-Sprouse, Sadeghin, et al., 2013; Samango-Sprouse
et al., 2015). Our current study adds further support for the potential
effect of testosterone on verbal and perceptual reasoning, cognitive
inhibition, and externalizing behaviors. Our findings suggest that some
aspects of the neurodevelopmental disturbances of 47,XXY may be
treatable by hormonal replacement, but further research is necessary
on this relationship. Additionally, there may be a window of
opportunity for optimal treatment, and additional study is warranted
and underway on the optimal timing of hormonal treatment.
There is evidence that scores from the CBCL Internalizing scale
may have the ability to discriminate between childrenwith andwithout
anxiety disorder (Seligman, Ollendick, Langley, & Baldacci, 2004).
Behavioral dysfunction, such as anxiety disorders, low levels of
testosterone, and high levels of estradiol, have been characterized in
the phenotypic profile of 47,XXY as far back as the 1970's (Caldwell &
Smith, 1972; Money, Annecillo, Orman, & Borgaonkar, 1974). In our
study, prenatal diagnosis was the only significant predictor for
decreased CBCL Internalizing problems, while testosterone was the
only significant predictor for decreased CBCL Externalizing problems.
Although this study did not find a relationship between testosterone
and internalizing behavior problems, previous studies have shown a
decrease in anxiety when boys with 47,XXY were treated with
androgens during infancy, and between 6 and 12 years of age (Ross
et al., 2017; Samango-Sprouse, Sadeghin, et al., 2013). More in-depth
studies are warranted to further understand this interaction and
relationship with hormonal production.
Results on the ANT assessment further expose the selective
variability within the neurocognitive function associated with 47,XXY.
Although individual variability was wide, the distribution was similar
between the two international samples. Of note, the ANT subtest that
showed significant group differences was Attention Regulation
(p = .001), which was also the subtest that displayed the most variance
due to external variables (Timing of Diagnosis and Testosterone). The
lack of statistical significance for the other ANT subtests (Attentional
Control, Inhibition,Mental Flexibility,Motor Fluency,Motor Flexibility,
Face Processing, and Facial Emotion Recognition: Happy, Sad, Angry)
suggests that these domains are more penetrant and less impacted by
external variables. Taken together, these findings provide support for
the need of targeted neuropsychological screening, treatment, and
early detection for the boys with 47,XXY with this disorder.
In both samples, boys with 47,XXY were most vulnerable in motor
flexibility with approximately half of the boys (US = 55.6%, NL = 44.2%)
having impairments. Mental flexibility was also highly and consistently
impacted, with 35.2% (US) and 35.7% (NL) of the children having
dysfunctions in this domain. Our results support that the executive
components of mental and motor flexibility may be more affected than
previously appreciated. The flexibility component seems to be a rather
penetrant aspect of the phenotype andwas not significantly influenced
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by testosterone treatment, parental education, or timing of diagnosis in
either cohort. Given that 47,XXY boys are known to be at high risk for
neurodevelopmental disturbances and executive dysfunction, compre-
hensive screening iswarranted at specific times to identify and treat any
neurodevelopmental dysfunction.
In our study, significant differences between samples in internal-
izing problem behavior were observed with time of diagnosis
(prenatal/postnatal). Timing of diagnosis may play a role as this allows
for early diagnosis, parental support, and psychosocial or pharmaco-
logical treatment. There is an overall lack of studies on early
intervention in children with 47,XXY, and current findings call for
further investigation. These findings suggest that the development of
syndrome-specific and targeted treatment may be fruitful in reducing
internalizing dysfunction and could be implemented across popula-
tions of boys with 47,XXY.
Further investigation is warranted in both populations to identify
other factors indicating phenotypic vulnerability and, conversely, other
potential positive contributors in boys with 47,XXY and/or their
environment.
Limitations of the study may include different recruitment
methods for NL and US participants and diverse care approaches in
the two countries. Additionally, this study is inherently predisposed to
ascertainment bias, as children who are referred to these centers for
care may not be representative of the entire 47,XXY population, of
which 75% never get diagnosed (Abramsky & Chapple, 1997; Bojesen
et al., 2003).
5 | CONCLUSION
Our prospective study revealed that several external factorsmay play a
significant role in understanding variability and penetrance in cognitive
and behavioral outcome in 47,XXY, both within and across samples.
Parental education, timing of diagnosis, and hormonal treatment all
played an important role in neurocognitive performance. Identifying
external factors in children with 47,XXY that may have a positive
influence on outcome, such as timing of diagnosis, parental support,
and testosterone treatment, is very important for improving clinical
care. These findings provide a further foundation for the development
of an outcome algorithm to identify vulnerable individuals with 47,XXY
in order to provide them with care as soon as possible. Further studies
are underway to identify and quantify other critical factors in infancy
through early childhood in order to optimize the outcome for all boys
with 47,XXY.
ACKNOWLEDGMENTS
Wewould like to express our deep gratitude to all our participants and
their families from the Netherlands and United States. We would like
to thank The Focus Foundation for their continued funding of our
investigative studies. Lastly, we would like to thank the Netherlands
Organization for Scientific Research for their VENI grant (number
016.095.060 to Sophie van Rijn) that helped to fund this study.
CONFLICTS OF INTEREST
The ANT program, used in this study, is commercially distributed by
Sonares BV, Amsterdam, The Netherlands. Leo de Sonneville is the
director of this firm. The rest of the authors declare that they have no
competing interests.
ETHICS APPROVAL
All participants were consented prior to participation. For the
Netherlands cohort, ethics approval was given by The Dutch Central
Committee on Research Involving Human Subjects. For the United
States cohort, ethics approval was given by the WIRB, protocol
#20081226.
AUTHORS CONTRIBUTION
CS-S: study design, drafting of manuscript, editing manuscript, general
oversight. ES: initial drafting of manuscript. PL: editing manuscript. SC:
editing manuscript. TS: study design, general oversight. CC: editing
manuscript. LdS: creator of one of the neuropsychological assessments
used, statistical analyses. SvR: study design, editing manuscript,




Abramsky, L., & Chapple, J. (1997). 47,XXY (Klinefelter syndrome) and 47,
XYY: Estimated rates of and indication for postnatal diagnosis with
implications for prenatal counselling. Prenatal Diagnosis, 17, 363–368.
Achenbach, T. M., & Edlebrock, C. (1991). Manual for the Child Behavior
Checklist Burlington. VT: University of Vermont.
Boada, R., Janusz, J., Hutaff-Lee, C., & Tartaglia, N. (2009). The cognitive
phenotype in Klinefelter syndrome: A review of the literature including
genetic and hormonal factors. Developmental Disabilities Research
Reviews, 15, 284–294.
Bojesen, A., Juul, S., & Gravholt, C. H. (2003). Prenatal and postnatal
prevalence of Klinefelter syndrome: A national registry study. The
Journal of Clinical Endocrinology & Metabolism, 88, 622–626.
Bruining, H., van Rijn, S., Swaab, H., Giltay, J., Kates, W., Kas, M. J., . . . de
Sonneville, L. (2010). The parent-of-origin of the extra X chromosome
may differentially affect psychopathology in Klinefelter syndrome.
Biological Psychiatry, 68, 1156–1162.
Caldwell, P. D., & Smith, D. W. (1972). The XXY (Klinefelter's) syndrome in
childhood: Detection and treatment. The Journal of Pediatrics, 80, 250–258.
de Sonneville, L. M. J. (1999). Amsterdam neuropsychological tasks: A
computer-aided assessment program.Computers in Psychology,6, 187–203.
de Sonneville, L. M. J. (2005). Amsterdam neuropsychological tasks:
Scientific and clinical applications. Tijdschrift voor Neuropsychologie, 1,
27–41.
Girardin, C.M., Lemyre, E., Alos, N., Deal, C., Huot, C., & VanVliet, G. (2009).
Comparison of adolescents with Klinefelter syndrome according to the
circumstances of diagnosis: Amniocentesis versus clinical signs.
Hormone Research in Paediatrics, 72, 98–105.
Hollingshead, A. B. (1975). Four-factor index of social status. Unpublished
manuscript, Department of Sociology, Yale University.
8 | SAMANGO-SPROUSE ET AL.884 | SAMANGO-SPROUSE ET AL.
Iitsuka, Y., Bock, A., Nguyen, D. D., Samango-Sprouse, C., Simpson, J. L., &
Bischoff, F. Z. (2001). Evidence of skewed X-chromosome inactivation
in 47,XXY and 48, XXYY klinefelter patients.American Journal ofMedical
Genetics, 98, 25–31.
Kompus, K., Westerhausen, R., Nilsson, L. G., Hugdahl, K., Jongstra, S.,
Berglund, A., . . . Savic, I. (2011). Deficits in inhibitory executive functions
in Klinefelter (47,XXY) syndrome. Psychiatry Research, 189, 135–140.
Lee, N. R., Wallace, G. L., Clasen, L. S., Lenroot, R. K., Blumenthal, J. D.,
White, S. L., . . . Giedd, J. N. (2011). Executive function in young males
with Klinefelter (XXY) syndrome with and without comorbid attention-
deficit/hyperactivity disorder. Journal of the International Neuropsycho-
logical Society, 17, 522–530.
Leggett, V., Jacobs, P., Nation, K., Scerif, G., & Bishop, D. V. (2010).
Neurocognitive outcomes of individuals with a sex chromosome
trisomy: XXX, XYY, or XXY: A systematic review. Developmental
Medicine & Child Neurology, 52, 119–129.
Linden, M. G., & Bender, B. G. (2002). Fifty-one prenatally diagnosed
children and adolescents with sex chromosome abnormalities.American
Journal of Medical Genetics, 110, 11–18.
Mandoki, M.W., & Sumner, G. S. (1991). Klinefelter syndrome: The need for
early identification and treatment. Clinical Pediatrics, 30, 161–164.
Mehta, A., & Paduch, D. A. (2012). Klinefelter syndrome: An argument for
early aggressive hormonal and fertility management. Fertility and
Sterility, 98, 274–283.
Mohd Nor, N. S., & Jalaludin, M. Y. (2016). A rare 47 XXY/46 XX mosaicism
with clinical features of Klinefelter syndrome. International Journal of
Pediatric Endocrinology, 2016, 1–4.
Money, J., Annecillo, C., Orman, B. V., & Borgaonkar, D. S. (1974).
Cytogenetics, hormones and behavior disability: Comparison of XYY
and XXY syndromes. Clinical Genetics, 6(5), 370–382.
Nielsen, J., &Wohlert, M. (1991). Chromosome abnormalities found among
34910 newborn children: Results from a 13-year incidence study in
Århus, Denmark. Human Genetics, 87, 81–83.
Patwardhan, A. J., Eliez, S., Bender, B., Linden, M. G., & Reiss, A. L. (2000).
Brain morphology in Klinefelter syndrome Extra X chromosome and
testosterone supplementation. Neurology, 54, 2218–2223.
Perwein, E. (1984). Incidence of klinefelter's syndrome. Klinefeleter's
Syndrome. Berlin: Springer, (pp. 8–11).
Rommelse, N. N. J., Altink, M. E., Oosterlaan, J., Buschgens, C. J. M.,
Buitelaar, J., & Sergeant, J. A. (2008). Support for an independent
familial segregation of executive and intelligence endophenotypes in
ADHD families. Psychological Medicine, 38, 1595–1606.
Ross, J. L., Kushner, H., Kowal, K., Bardsley, M., Davis, S., Reiss, A. L., . . .
Roeltgen, D. (2017). Androgen treatment effects on motor function,
cognition, and behavior in boys with Klinefelter syndrome. The Journal
of Pediatrics, 185, 193–199.
Ross, J. L., Roeltgen, D. P., Kushner, H., Zinn, A. R., Reiss, A., Bardsley, M. Z.,
. . . Tartaglia, N. (2012). Behavioral and social phenotypes in boys with
47, XYY syndrome or 47,XXY Klinefelter syndrome. Pediatrics, 129,
769–778.
Ross, J. L., Samango-Sprouse, C., Lahlou, N., Kowal, K., Elder, F. F., & Zinn,
A. (2005). Early androgen deficiency in infants and young boys with
47,XXY Klinefelter syndrome. Hormone Research in Paediatrics, 64,
39–45.
Samango-Sprouse, C., & Rogol, A. (2002). XXY: The hidden disability and a
prototype for an infantile presentation of developmental dyspraxia
(IDD). Infants & Young Children, 15, 11–18.
Samango-Sprouse, C., Sadeghin, T., Mitchell, F. L., Dixon, T., Stapleton, E.,
Kingery, M., & Gropman, A. L. (2013). Positive effects of short course
androgen therapy on the neurodevelopmental outcome in boyswith 47,
XXY syndrome at 36 and 72 months of age. American Journal of Medical
Genetics Part A, 161A, 501–508.
Samango-Sprouse, C., Stapleton, E. J., Lawson, P., Mitchell, F., Sadeghin, T.,
Powell, S., & Gropman, A. L. (2015). Positive effects of early androgen
therapy on the behavioral phenotype of boys with 47,XXY. American
Journal of Medical Genetics Part C: Seminars in Medical Genetics, 169,
150–157.
Samango-Sprouse, C., Stapleton, E. J., Mitchell, F. L., Sadeghin, T., Donahue,
T. P., & Gropman, A. L. (2014). Expanding the phenotypic profile of boys
with 47,XXY: The impact of familial learning disabilities. American
Journal of Medical Genetics Part A, 164A, 1464–1469.
Samango-Sprouse, C., Stapleton, E., Sadeghin, T., & Gropman, A. L. (2013).
Is it all the X: Familial learning dysfunction and the impact of behavioral
aspects of the phenotypic presentation of XXY? American Journal of
Medical Genetics Part C: Seminars in Medical Genetics, 163, 27–34.
Seligman, L. D., Ollendick, T. H., Langley, A. K., & Baldacci, H. B. (2004).
The utility of measures of child and adolescent anxiety: A meta-
analytic review of the Revised Children's Manifest Anxiety Scale, the
State-Trait Anxiety Inventory for Children, and the Child Behavior
Checklist. Journal of Clinical Child and Adolescent Psychology, 33,
557–565.
Serra, M., Althaus, M., de Sonneville, L. M. J., Stant, A. D., Jackson, A. E., &
Minderaa, R. B. (2003). Face recognition in children with a pervasive
developmental disorder not otherwise specified. Journal of Autism and
Developmental Disorders, 33, 303–317.
Simpson, J. L., de la Cruz, F., Swerdloff, R. S., Samango-Sprouse, C.,
Skakkebaek, N. E., Graham, J. M., & Hall, J. G. (2003). Klinefelter
syndrome: Expanding the phenotype and identifying new research
directions. Genetics in Medicine, 5, 460–468.
Tartaglia, N. R., Ayari, N., Hutaff-Lee, C., & Boada, R. (2012). Attention-
deficit hyperactivity disorder symptoms in children and adolescents
with sex chromosome aneuploidy: XXY, XXX, XYY, and XXYY. Journal of
Developmental and Behavioral Pediatrics, 33, 309–318.
Wechsler, D. (1991).Manual for the Wechsler Intelligence Scale for Children-
(WISC-III). San Antonio, TX: Psychological Corporation.
Wechsler, D. (2005). WAIS-III NL. Wechsler Adult Intelligence Scale WAIS-
III (3rd ed.). Dutch version. Manual. Amsterdam: Harcourt Test
Publishers.
van Rijn, S., & Swaab, H. (2015). Executive dysfunction and the relationwith
behavioral problems in children with 47, XXY and 47, XXX. Genes, Brain
and Behavior, 14, 200–208.
SUPPORTING INFORMATION
Additional Supporting Information may be found online in the
supporting information tab for this article.
How to cite this article: Samango-Sprouse C, Stapleton E,
Chea S, et al. International investigation of neurocognitive
and behavioral phenotype in 47,XXY (Klinefelter syndrome):
Predicting individual differences. Am J Med Genet Part A.
2018;1–9. https://doi.org/10.1002/ajmg.a.38621
SAMANGO-SPROUSE ET AL. | 9
76:877–885. https: /doi.org/10.1002/ajmg.a.38621
SAMANGO-SPROUSE ET AL. | 885
